Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct

被引:81
作者
Imrell, Kerstin
Landtblom, Anne-Marie
Hillert, Jan
Masterman, Thomas
机构
[1] Karolinska Inst, Div Neurol, Dept Clin Neurosci, Stockholm, Sweden
[2] Linkoping Univ, Div Neurol, Dept Neurosci & Locomot, Fac Hlth Sci, Linkoping, Sweden
关键词
PREDICT CONVERSION; OLIGOCLONAL IGG; CRITERIA;
D O I
10.1212/01.wnl.0000237343.93389.35
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We sought to determine whether Swedish patients with multiple sclerosis ( MS) with and without oligoclonal bands (OCBs) in the CSF constitute distinct subpopulations, clinically and immunogenetically. Our findings indicate that OCB-negative MS shares the same clinical features as OCB-positive MS regarding female predominance, age at onset, proportion of primary progressive cases, rate of MRI positivity, and disease severity. Our HLA-DRB1 genotyping results suggest, however, that OCB-positive and OCB-negative MS are immunogenetically distinct.
引用
收藏
页码:1062 / 1064
页数:3
相关论文
共 9 条
[1]   Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
Miller, DH ;
Scheltens, P ;
Campi, A ;
Polman, CH ;
Comi, G ;
Ader, HJ ;
Losseff, N ;
Valk, J .
BRAIN, 1997, 120 :2059-2069
[2]   HILA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands [J].
Kikuchi, S ;
Fukazawa, T ;
Niino, M ;
Yabe, I ;
Miyagishi, R ;
Hamada, T ;
Hashimoto, SA ;
Tashiro, K .
NEUROLOGY, 2003, 60 (04) :647-651
[3]   SARDINIAN MULTIPLE-SCLEROSIS IS ASSOCIATED WITH HLA-DR4 - A SEROLOGIC AND MOLECULAR ANALYSIS [J].
MARROSU, MG ;
MUNTONI, F ;
MURRU, MR ;
SPINICCI, G ;
PISCHEDDA, MP ;
GODDI, F ;
COSSU, P ;
PIRASTU, M .
NEUROLOGY, 1988, 38 (11) :1749-1753
[4]   Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis [J].
McDonald, WI ;
Compston, A ;
Edan, G ;
Goodkin, D ;
Hartung, HP ;
Lublin, FD ;
McFarland, HF ;
Paty, DW ;
Polman, CH ;
Reingold, SC ;
Sandberg-Wollheim, M ;
Sibley, W ;
Thompson, AJ ;
van den Noort, S ;
Weinshenker, BY ;
Wolinsky, JS .
ANNALS OF NEUROLOGY, 2001, 50 (01) :121-127
[5]  
OLSSON T, 1984, CLIN CHEM, V30, P1246
[6]   Multiple sclerosis severity score -: Using disability and disease duration to rate disease severity [J].
Roxburgh, RHSR ;
Seaman, SR ;
Masterman, T ;
Hensiek, AE ;
Sawcer, SJ ;
Vukusic, S ;
Achiti, I ;
Confavreux, C ;
Coustans, M ;
le Page, E ;
Edan, G ;
McDonnell, GV ;
Hawkins, S ;
Trojano, M ;
Liguori, M ;
Cocco, E ;
Marrosu, MG ;
Tesser, F ;
Leone, MA ;
Weber, A ;
Zipp, F ;
Miterski, B ;
Epplen, JT ;
Oturai, A ;
Sorensen, PS ;
Celius, EG ;
Lara, NT ;
Montalban, X ;
Villoslada, P ;
Silva, AM ;
Marta, M ;
Leite, I ;
Dubois, B ;
Rubio, J ;
Butzkueven, H ;
Kilpatrick, T ;
Mycko, MP ;
Selmaj, KW ;
Rio, ME ;
Sá, M ;
Salemi, G ;
Savettieri, G ;
Hillert, J ;
Compston, DAS .
NEUROLOGY, 2005, 64 (07) :1144-1151
[7]  
Tintoré M, 2000, AM J NEURORADIOL, V21, P702
[8]   HLA class II association with rheumatoid arthritis - Facts and interpretations [J].
Zanelli, E ;
Breedveld, FC ;
de Vries, RRP .
HUMAN IMMUNOLOGY, 2000, 61 (12) :1254-1261
[9]   A study of oligoclonal band negative multiple sclerosis [J].
Zeman, AZJ ;
Kidd, D ;
McLean, BN ;
Kelly, MA ;
Francis, DA ;
Miller, DH ;
Kendall, BE ;
Rudge, P ;
Thompson, EJ ;
McDonald, WI .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (01) :27-30